Likewise, metformin-induced AMPK and Sirt1 activation has been shown to lower p53 protein levels in hepatoma cells exposed to high glucose, whereas the overexpression of p53 in this context attenuated the effects of metformin on AMPK activation (Nelson et al., 2012). The gene discussed is TP53; the disease is hepatocellular carcinoma.